SA Weinzimer, GM Steil, KL Swan, J Dziura, … - Diabetes Care, 2008 - Am Diabetes Assoc OBJECTIVE—The most promising β-cell replacement therapy for children with
type 1 diabetes is a closed-loop artificial pancreas incorporating continuous
glucose sensors and insulin pumps. The Medtronic MiniMed external ... Cited by 30 - Related articles - BL Direct - All 5 versions
GM Steil, K Rebrin, C Darwin, F Hariri, MF … - Diabetes, 2006 - Am Diabetes Assoc An automated closed-loop insulin delivery system based on subcutaneous glucose
sensing and subcutaneous insulin delivery was evaluated in 10 subjects with type
1 diabetes (2 men, 8 women, mean [±SD] age 43.4 ± 11.4 years, duration of ... Cited by 41 - Related articles - BL Direct - All 5 versions
FH El-Khatib, J Jiang, RG Gerrity, ER … - Diabetes Technology & Therapeutics, 2007 - liebertonline.com FIRAS H. EL-KHATIB, Ph.D., 1 JOHN JIANG, BS, 1 ROSS G. GERRITY, Ph.D., 2 ...
Background: The objective of this study was to determine the in vivo
pharmacodynamics of glucagon and to test its glycemic effect over days by ... Cited by 5 - Related articles - BL Direct - All 3 versions
SA Weinzimer, WV Tamborlane - Current Opinion in Endocrinology, Diabetes and …, 2008 - journals.lww.com Purpose of review: Recent developments in technology have ushered in a new era
of managing type 1 diabetes. Continuous glucose monitoring is rapidly becoming
an accepted adjunct to traditional self-monitoring of plasma glucose, and ... Cited by 10 - Related articles - BL Direct - All 2 versions
- ►diabetesjournals.org DM Wilson, RW Beck, WV Tamborlane, MJ … - Diabetes Care, 2007 - Am Diabetes Assoc RESEARCH DESIGN AND METHODS—In 30 children with type 1 diabetes (mean age 11.2
± 4.1 years), the Navigator glucose values were compared with reference serum
glucose values of blood samples obtained in an inpatient clinical research ... Cited by 42 - Related articles - BL Direct - All 6 versions
- Free from Publisher E Dassau, BW Bequette, BA Buckingham, FJ … - Diabetes Care, 2008 - Am Diabetes Assoc RESEARCH DESIGN AND METHODS—We developed our MDA on a dataset of 26 meal
events using records from 19 children aged 1–6 years who used the MiniMed CGMS
Gold. We then applied this algorithm to CGM records from a DirecNet pilot ... Cited by 12 - Related articles - BL Direct - All 5 versions
BP Kovatchev, M Breton, C Dalla Man, C … - Journal of diabetes science and technology (Online), 2009 - pubmedcentral.nih.gov Arguably, a minimally invasive system using subcutaneous (sc) continuous glucose
monitoring (CGM) and sc insulin delivery via insulin pump would be a most
feasible step to closed-loop control in type 1 diabetes mellitus (T1DM). ... Cited by 3 - Related articles - All 3 versions
